Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

被引:119
作者
Oldenburg, J. [1 ,2 ]
Berney, D. M. [3 ,4 ]
Bokemeyer, C. [5 ]
Climent, M. A. [6 ]
Daugaard, G. [7 ]
Gietema, J. A. [8 ]
De Giorgi, U. [9 ]
Haugnes, H. S. [10 ,11 ]
Huddart, R. A. [12 ,13 ]
Leao, R. [14 ]
Sohaib, A. [15 ]
Gillessen, S. [16 ,17 ,18 ]
Powles, T. [4 ]
机构
[1] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway
[2] Univ Oslo, Fac Med, Oslo, Norway
[3] Queen Mary Univ London, Barts Canc Inst, Dept Cellular Pathol, London, England
[4] Barts Hlth NHS Trust, London, England
[5] Univ Med Ctr Hamburg Eppendorf, Sect Pneumol, Dept Oncol Hematol Bone Marrow Transplantat, Hamburg, Germany
[6] Fdn Inst Valenciano Oncol, Valencia, Spain
[7] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark
[8] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands
[9] IRCCS Ist Romagnolo Tumori IRST Dino Amadori, Dept Med Oncol, Meldola, Italy
[10] Univ Hosp North Norway, Dept Oncol, Tromso, Norway
[11] UiT Arctic Univ, Tromso, Norway
[12] Inst Canc Res, London, England
[13] Royal Marsden Fdn Trust, London, England
[14] Univ Coimbra, Dept Urol, Hosp Braga, Hosp CUF Coimbra,Fac Med, Coimbra, Portugal
[15] Royal Marsden Hosp, Dept Diagnost Radiol, Sutton, Surrey, England
[16] EOC, Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[17] USI, Fac Biomed Sci, Lugano, Switzerland
[18] Univ Manchester, Div Canc Med, Manchester, Lancs, England
关键词
seminoma; non-seminoma; testicular cancer; ESMO Clinical Practice Guideline; treatment; recommendations; GERM-CELL TUMORS; STAGE-I SEMINOMA; HIGH-DOSE CHEMOTHERAPY; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; ADJUVANT CARBOPLATIN; CONSENSUS CONFERENCE; MICRORNAS MIR-371-3; AMERICAN SOCIETY; SERUM BIOMARKERS;
D O I
10.1016/j.annonc.2022.01.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:362 / 375
页数:14
相关论文
共 101 条
[1]   Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors [J].
AlDubayan, Saud H. ;
Pyle, Louise C. ;
Gamulin, Marija ;
Kulis, Tomislav ;
Moore, Nathanael D. ;
Taylor-Weiner, Amaro ;
Hamid, Anis A. ;
Reardon, Brendan ;
Wubbenhorst, Bradley ;
Godse, Rama ;
Vaughn, David J. ;
Jacobs, Linda A. ;
Meien, Stefanie ;
Grgic, Mislav ;
Kastelan, Zeljko ;
Markt, Sarah C. ;
Damrauer, Scott M. ;
Rader, Daniel J. ;
Kember, Rachel L. ;
Loud, Jennifer T. ;
Kanetsky, Peter A. ;
Greene, Mark H. ;
Sweeney, Christopher J. ;
Kubisch, Christian ;
Nathanson, Katherine L. ;
Van Allen, Eliezer M. ;
Stewart, Douglas R. ;
Lessel, Davor ;
Van Hout, Cristopher ;
O'Dushlaine, Colm ;
Li, Alexander ;
McCarthy, Shane ;
Marcketta, Anthony ;
Ye, Bin ;
Dostal, Tanya Teslovich ;
Schurmann, Claudia ;
Gurski, Lauren ;
Sun, Dylan ;
Liu, Daren ;
Abecasis, Goncalo ;
Marchini, Jonathan ;
Reid, Jeffrey ;
Ulloa, Ricardo ;
Habegger, Lukas ;
Penn, John ;
Bai, Xiaodong ;
Hahn, Young ;
Staples, Jeffrey ;
Maxwell, Evan ;
Manoochehri, Kia .
JAMA ONCOLOGY, 2019, 5 (04) :514-522
[2]   Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007) [J].
Andreassen, Kristine E. ;
Grotmol, Tom ;
Cvancarova, Milada S. ;
Johannesen, Tom B. ;
Fossa, Sophie D. .
INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (12) :2867-2874
[3]   Clinicopathological Study of Regressed Testicular Tumors (Apparent Extragonadal Germ Cell Neoplasms) [J].
Angulo, Javier C. ;
Gonzalez, Javier ;
Rodriguez, Nuria ;
Hernandez, Emilio ;
Nunez, Carlos ;
Rodriguez-Barbero, Jose M. ;
Santana, Alicia ;
Lopez, Jose I. .
JOURNAL OF UROLOGY, 2009, 182 (05) :2303-2310
[4]  
[Anonymous], 1997, J Clin Oncol, V15, P594
[5]   Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG) [J].
Aparicio, J. ;
Maroto, P. ;
Garcia del Muro, X. ;
Sanchez-Munoz, A. ;
Guma, J. ;
Margeli, M. ;
Saenz, A. ;
Sagastibelza, N. ;
Castellano, D. ;
Arranz, J. A. ;
Hervas, D. ;
Bastus, R. ;
Fernandez-Aramburo, A. ;
Sastre, J. ;
Terrasa, J. ;
Lopez-Brea, M. ;
Dorca, J. ;
Almenar, D. ;
Carles, J. ;
Hernandez, A. ;
Germa, J. R. .
ANNALS OF ONCOLOGY, 2014, 25 (11) :2173-2178
[6]   Risk-adapted management for patients with clinical stage I seminoma:: The second Spanish germ cell cancer cooperative group study [J].
Aparicio, J ;
Germà, JR ;
del Muro, XG ;
Maroto, P ;
Arranz, JA ;
Sáenz, A ;
Barnadas, A ;
Dorca, J ;
Gumà, J ;
Olmos, D ;
Bastús, R ;
Carles, J ;
Almenar, D ;
Sánchez, M ;
Paz-Ares, L ;
Satrústegui, JJ ;
Mellado, B ;
Balil, A ;
López-Brea, M ;
Sánchez, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8717-8723
[7]   Value of Multiparametric US in the Assessment of Intratesticular Lesions [J].
Auer, Thomas ;
De Zordo, Tobias ;
Dejaco, Christian ;
Gruber, Leonhard ;
Pichler, Renate ;
Jaschke, Werner ;
Dogra, Vikram S. ;
Aigner, Friedrich .
RADIOLOGY, 2017, 285 (02) :640-649
[8]   Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors [J].
Bagrodia, Aditya ;
Lee, Byron H. ;
Lee, William ;
Cha, Eugene K. ;
Sfakianos, John P. ;
Iyer, Gopa ;
Pietzak, Eugene J. ;
Gao, Sizhi Paul ;
Zabor, Emily C. ;
Ostrovnaya, Irina ;
Kaffenberger, Samuel D. ;
Syed, Aijazuddin ;
Arcila, Maria E. ;
Chaganti, Raju S. ;
Kundra, Ritika ;
Eng, Jana ;
Hreiki, Joseph ;
Vacic, Vladimir ;
Arora, Kanika ;
Oschwald, Dayna M. ;
Berger, Michael F. ;
Bajorin, Dean F. ;
Bains, Manjit S. ;
Schultz, Nikolaus ;
Reuter, Victor E. ;
Sheinfeld, Joel ;
Bosl, George J. ;
Al-Ahmadie, Hikmat A. ;
Solit, David B. ;
Feldman, Darren R. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (33) :4000-U102
[9]  
Baird DC, 2018, AM FAM PHYSICIAN, V97, P261
[10]   Serum tumor markers in the evaluation of male germ cell tumors [J].
Barlow, LaMont J. ;
Badalato, Gina M. ;
McKiernan, James M. .
NATURE REVIEWS UROLOGY, 2010, 7 (11) :610-617